Number of the records: 1
Targeted strategy in lipid-lowering therapy
Title Targeted strategy in lipid-lowering therapy Author Saman Ezgi 1989- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV SCOPUS ORCID Co-authors Pecháňová Oľga 1962- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV SCOPUS ORCID Source document Biomedicines. Vol. 10, no. 5 (2022), art. no. 1090, p. [1-18] Language eng - English Country CH - Switzerland URL URL link Document kind rozpis článkov z periodík (rbx) Citations STANCIULESCU, Laura-Adina - SCAFA, Alexandru - DUDUIANU, Catalin - STAN, Raluca - NICOLESCU, Alina - DELEANU, Calin - DOROBANTU, Maria. Lipoprofiling Assessed by NMR Spectroscopy in Patients with Acute Coronary Syndromes: Is There a Need for Fasting Prior to Sampling? In DIAGNOSTICS, 2022, vol. 12, no. 7, art. no. 1675. Dostupné na: https://doi.org/10.3390/diagnostics12071675. BROGI, Simone - TABANELLI, Rita - CALDERONE, Vincenzo. Combinatorial approaches for novel cardiovascular drug discovery: a review of the literature. In EXPERT OPINION ON DRUG DISCOVERY, 2022, vol. 17, no. 10, p. 1111-1129, ISSN 1746-0441. Dostupné na: https://doi.org/10.1080/17460441.2022.2104247. LI, J.D. - XIONG, T. - WANG, T.Q. - WANG, M. - WANG, C. - YANG, F.Y. - WANG, X.D. - TAN, Z.J. - SUN, W.L. Baicalein targets CD36 to prevent foam cell formation by suppressing the excessive uptake of oxLDL and accelerating ABCA1-mediated cholesterol efflux in oxLDL-induced THP-1 macrophages. In JOURNAL OF FUNCTIONAL FOODS. ISSN 1756-4646, OCT 2022, vol. 97, art. no. 105253. QIAN, J.Y. - LI, Z.Q. - ZHANG, X.L. - CHEN, J.Y. - DING, C.H. - YANG, P. - LIU, Y. - SHI, M. - REN, X.R. - GE, J.B. Efficacy and Tolerability of Ezetimibe/Atorvastatin Fixed-dose Combination Versus Atorvastatin Monotherapy in Hypercholesterolemia: A Phase III, Randomized, Active-controlled Study in Chinese Patients. In CLINICAL THERAPEUTICS. ISSN 0149-2918, OCT 2022, vol. 44, no. 10, p. 1282-1296. OUYANG, M.Q. - LI, C.Y. - HU, D. - PENG, D.Q. - YU, B.L. Mechanisms of unusual response to lipid-lowering therapy: PCSK9 inhibition. In CLINICA CHIMICA ACTA. ISSN 0009-8981, JAN 1 2023, vol. 538, p. 113-123. RACHITHA, P. - KRISHNASWAMY, K. - LAZAR, R.A. - GUPTA, V.K. - INBARAJ, B.S. - RAGHAVENDRA, V.B. - SHARMA, M. - SRIDHAR, K. Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches. In BIOENGINEERING-BASEL. JAN 2023, vol. 10, no. 1, art. no. 64. BOUTARI, C. - RIZOS, C.V. - DOUMAS, M. - LIAMIS, G. - SKOUMAS, I. - RALLIDIS, L. - GAROUFI, A. - KOLOVOU, G. - TZIOMALOS, K. - SKALIDIS, E. - KOTSIS, V. - SFIKAS, G. - LAMBADIARI, V. - ANAGNOSTIS, P. - BILIANOU, E. - ANASTASIOU, G. - KOUTAGIAR, I. - KIOURI, E. - ATTILAKOS, A. - KOLOVOU, V. - ZACHARIS, E. - ANTZA, C. - LIBEROPOULOS, E. Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). In PHARMACEUTICALS. JAN 2023, vol. 16, no. 1, art. no. 44. MONTELIONE, N. - LORENI, F. - NENNA, A. - CATANESE, V. - SCURTO, L. - FERRISI, C. - JAWABRA, M. - GABELLINI, T. - CODISPOTI, F.A. - SPINELLI, F. - CHELLO, M. - STILO, F. Tissue Engineering and Targeted Drug Delivery in Cardiovascular Disease: The Role of Polymer Nanocarrier for Statin Therapy. In BIOMEDICINES. MAR 2023, vol. 11, no. 3, art. no. 798. PHAM, V. - MORONI, A. - GALL, E. - BENEDETTI, A. - ZIVELONGHI, C. - PICARD, F. Revascularization and Medical Therapy for Chronic Coronary Syndromes: Lessons Learnt from Recent Trials, a Literature Review. In JOURNAL OF CLINICAL MEDICINE. APR 2023, vol. 12, no. 8, art. no. 2833. SONG, Z.L. - MENG, S.Y. - TANG, Z. - YANG, X.X. - HE, Y. - ZHENG, Y. - GUO, H. - DU, M.R. - ZHU, Y.Z. - WANG, X.L. Injectable leonurine nanocrystal-loaded microspheres for long-term hyperlipidemia management. In BIOMATERIALS SCIENCE. ISSN 2047-4830, JUN 27 2023, vol. 11, no. 13, p. 4713-4726. ZHU, Y. - XU, Y.N. - HAN, D. - ZHANG, X.J. - QIN, C. - LIU, J. - TIAN, L. - XU, M.Q. - FANG, Y. - ZHANG, Y. - WANG, Y.B. - CAO, F. Scavenger receptor-AI targeted theranostic nanoparticles for regression of atherosclerotic plaquesi via/i ABCA1 modulation. In NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE. ISSN 1549-9634, JUN 2023, vol. 50, art. no. 102672. CONDE, A.C. - MARTíN, D.M. - RUIZ, R.C. - OLMO, M.R.F. - ARIñO, C.M. - DOBLAS, J.J.G. - TERUEL, J.L.G. - RAMOS, P.M. - MARIMON, X.G.M. - ROMEO, M.J.S. - JIMéNEZ, D.L. - ESTEBAN, V.A. - REBOLLAR, J.C.O. - CERVANTES, C.E. - MARTíNEZ, J.J.G. Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes. In JOURNAL OF CLINICAL MEDICINE. JUN 2023, vol. 12, no. 12, art. no. 3925. AHMED, F. - MUSTAFA, M.A. - TAYYAB, M. - SARWER, M.U. - KHAN, H.U. - ZAHEER, L. Fabrication and In vitro evaluation of chitosan-based nanocomposites through ionic gelation method for the sustained release drug delivery of nicorandil. In ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE. ISSN 2250-1444, OCT-DEC 2023, vol. 15, no. 4, p. 338-346. TAKEUCHI, A. - YE, Y. - TAKADA, K. - MORI, R. - NAKAMURA, T. - ODA, N. - MIJITI, M. - BANNO, A. - NAGAOKA, S. Pentapeptide IIAEK ameliorates cholesterol metabolism via the suppression of intestinal cholesterol absorption in mice. In BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY. ISSN 0916-8451, OCT 25 2023, vol. 87, no. 11, p. 1345-1353. YOUSEFI, M. - FATEH, S.T. - NIKBAF-SHANDIZ, M. - GHOLAMI, F. - RASTGOO, S. - BAGHER, R. - KHADEM, A. - SHIRASEB, F. - ASBAGHI, O. The effect of acarbose on lipid profiles in adults: a systematic review and meta-analysis of randomized clinical trials. In BMC PHARMACOLOGY & TOXICOLOGY. NOV 22 2023, vol. 24, no. 1, art. no. 65. WANG, Tengfei - DUAN, Ruibin - YANG, Jiali - HUO, Meijun. Using Network Pharmacology and Molecular Docking to Explore the Mechanism by Which Dracocephalum rupestre Hance Tea Intervenes in Hyperlipidemia. In Shipin Kexue/Food Science, 2023-01-01, 44, 9, pp. 7-14. ISSN 10026630. Dostupné na: https://doi.org/10.7506/spkx1002-6630-20220721-245. SAHU, P. K. - KUMAR, P. S. - PRUSTY, S. K. Nanotherapeutics for management of dyslipidemia. In Metal Nanocomposites in Nanotherapeutics for Oxidative Stress-Induced Metabolic Disorders, 2023-12-18, pp. 211-227. Dostupné na: https://doi.org/10.1201/9781032621135-10. METWALLY, Mohamed A.A. - EL-ZAWAHRY, El Yamani I. - ALI, Maher A. - IBRAHIM, Diaa F. - SABRY, Shereen A. Rosuvastatin and Ezetimibe loaded PLGA: an investigation approach for the treatment of hyperlipidemia induced by Triton in male albino rats. In Journal of Advanced Veterinary Research, 2024-05-05, 14, 5, pp. 789-792. ISSN 20906269. BLAGOV, A. - SOBENIN, I. - SUKHORUKOV, V. - GLANZ, V. - PLESHKO, E. - OREKHOV, A. Development of Dyslipidemia in Atherosclerosis and Modern Approaches to its Treatment. In HEART SURGERY FORUM. ISSN 1098-3511, 2024, vol. 27, no. 6, p. E680-E688. SHEHATA, T.M. - ALDHUBIAB, B. - ELSEWEDY, H.S. Virgin Coconut Oil-based Nanostructured Lipid Carrier Improves the Hypolipidemic Effect of Rosuvastatin. In INTERNATIONAL JOURNAL OF NANOMEDICINE. ISSN 1178-2013, 2024, vol. 19, p. 7945-7961. CHARBE, N.B. - ZACCONI, F.C. - KOWTHAVARAPU, V.K. - GUPTA, C. - PALAKURTHI, S.S. - SATHEESHKUMAR, R. - LOKWANI, D.K. - TAMBUWALA, M.M. - PALAKURTHI, S. Targeting Allosteric Site of PCSK9 Enzyme for the Identification of Small Molecule Inhibitors: An In Silico Drug Repurposing Study. In BIOMEDICINES. FEB 2024, vol. 12, no. 2, art. no. 286. APETROAEI, M.M. - FRAGKIADAKI, P. - VELESCU, B.S. - BALIOU, S. - RENIERI, E. - DINU-PIRVU, C.E. - DRAGANESCU, D. - VLASCEANU, A.M. - NEDEA, M.I. - UDEANU, D.I. - DOCEA, A.O. - TSATSAKIS, A. - ARSENE, A.L. Pharmacotherapeutic Considerations on Telomere Biology: The Positive Effect of Pharmacologically Active Substances on Telomere Length. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1661-6596, JUL 2024, vol. 25, no. 14, art. no. 7694. ZOU, D. - HU, Q.Z. - LIU, Y. - YU, L. Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database. In INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. ISSN 2210-7703, 2024, vol. , no. , p. . NECHCHADI, H. - NADIR, Y. - BENHSSAINE, K. - ALEM, C. - SELLAM, K. - BOULBAROUD, S. - BERROUGUI, H. - RAMCHOUN, M. Hypolipidemic activity of phytochemical combinations: A mechanistic review of preclinical and clinical studies. In FOOD CHEMISTRY. ISSN 0308-8146, NOV 30 2024, vol. 459, art. no. 140264. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2022 Registered in WOS Registered in SCOPUS DOI 10.3390/biomedicines10051090 
article
File name Access Size Downloaded Type License Targeted strategy in lipid-lowering therapy.pdf available 2.9 MB 2 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2022 2021 4.757 Q2 0.874 Q1
Number of the records: 1